Streetbeat News

MGX

Metagenomi Inc.

Industry

Research and Development in Biotechnology (except Nanobiotechnology)

Open

1.85

Mkt cap

65M

Volume

562K

High

1.94

P/E Ratio

-0.73

52-wk high

11.86

Low

1.69

Div yield

N/A

52-wk low

1.61

Metagenomi, Inc. is facing a class action lawsuit filed by The Schall Law Firm for alleged violations of federal securities laws related to its IPO. Shareholders with losses are encouraged to contact the firm.

Portfolio Pulse from

November 15, 2024 | 5:15 pm

Levi & Korsinsky has notified shareholders of Metagenomi, Inc. (NASDAQ:MGX) about a class action lawsuit and an upcoming deadline for potential recovery under federal securities laws.

Portfolio Pulse from

November 15, 2024 | 5:00 pm

Faruqi & Faruqi, LLP is investigating claims on behalf of investors in Metagenomi. Investors who have suffered losses exceeding $50,000 are encouraged to contact the firm for potential legal action.

Portfolio Pulse from

November 15, 2024 | 4:30 pm

A class action lawsuit has been filed against Metagenomi, Inc. (NASDAQ:MGX) for investors who suffered losses. Investors are encouraged to contact Levi & Korsinsky for potential recovery under federal securities laws.

Portfolio Pulse from

November 15, 2024 | 12:45 pm

Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Metagenomi, Inc. (NASDAQ:MGX) and certain officers for alleged securities law violations related to their IPO. The lawsuit covers investors who acquired Metagenomi securities between February 9, 2024, and May 1, 2024.

Portfolio Pulse from

November 15, 2024 | 12:15 pm

Levi & Korsinsky, LLP has filed a securities class action lawsuit on behalf of Metagenomi, Inc. (NASDAQ: MGX) shareholders, alleging securities fraud and seeking to recover investor losses.

Portfolio Pulse from

November 15, 2024 | 11:00 am

Levi & Korsinsky has announced a lead plaintiff deadline of November 25, 2024, for a lawsuit involving Metagenomi, Inc. (NASDAQ:MGX). Shareholders who suffered losses are encouraged to seek potential recovery under federal securities laws.

Portfolio Pulse from

November 15, 2024 | 2:45 am

Faruqi & Faruqi, LLP is investigating claims against Metagenomi, Inc. (NASDAQ: MGX) for potential securities fraud. Investors who suffered losses over $50,000 between February 9, 2024, and September 26, 2024, are encouraged to contact the firm before the November 25, 2024 deadline to seek lead plaintiff status in a class action lawsuit.

Portfolio Pulse from

November 15, 2024 | 2:30 am

A class action lawsuit is pending against Metagenomi, Inc. (NASDAQ:MGX) for investors who suffered losses. Investors are encouraged to contact Levi & Korsinsky for potential recovery under federal securities laws.

Portfolio Pulse from

November 15, 2024 | 2:30 am

Metagenomi, Inc. (NASDAQ:MGX) is facing a lawsuit for securities law violations. Investors who have suffered losses are encouraged to contact Levi & Korsinsky for potential recovery options.

Portfolio Pulse from

November 14, 2024 | 10:15 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.